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a  b  s  t  r  a  c  t
Suboptimal  vaccine  uptake  in  both  childhood  and  adult  immunisation  programs  limits  their  full potential
impact  on  global  health.  A  recent  progress  review  of the Global  Vaccine  Action  Plan  stated  that  “countries
should  urgently  identify  barriers  and  bottlenecks  and  implement  targeted  approaches  to increase  and  sus-
tain  coverage”.  However,  vaccination  coverage  may  be determined  by  a complex  mix of demographic,
structural,  social  and  behavioral  factors.  To  develop  a practical  taxonomy  to organise  the  myriad  possible
root  causes  of a gap in vaccination  coverage  rates,  we performed  a  narrative  review  of the literature  and
tested whether  all non-socio-demographic  determinants  of  coverage  could  be organised  into  4  dimen-
sions:  Access,  Affordability,  Awareness  and  Acceptance.  Forty-three  studies  were  reviewed,  from  which
we identiﬁed  23  primary  determinants  of  vaccination  uptake.  We  identiﬁed  a ﬁfth  domain,  Activation,accination coverage
accine uptake
mmunisation rates
which  captured  interventions  such  as  SMS  reminders  which  effectively  nudge  people  towards  getting
vaccinated.  The  5As  taxonomy  captured  all identiﬁed  determinants  of vaccine  uptake.  This  intuitive
taxonomy  has  already  facilitated  mutual  understanding  of  the  primary  determinants  of suboptimal  cov-
erage within  inter-sectorial  working  groups,  a ﬁrst  step  towards  them  developing  targeted  and  effective
solutions.
© 2015  The  Authors.  Published  by Elsevier  Ltd.  This  is an  open  access  article  under  the  CC  BY-NC-ND
license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).. Introduction
A recent progress review of the Global Vaccine Action Plan
GVAP) stated that “countries should urgently identify barriers and
ottlenecks and implement targeted approaches to increase and sus-
ain coverage” in immunisation programs [1]. The EU council
ecently highlighted the failure of member states to reach inﬂuenza
accine coverage targets, leaving approximately 60 million elderly
nd at-risk patients unvaccinated every year [2,3]. To achieve the
oals of vaccination policies, programmatic and supply challenges
ust be addressed, but there is also increasing awareness that vac-
ine hesitancy, recently deﬁned a delay in acceptance or refusal of
accines despite availability of vaccination services [4], may  be an
mportant cause of suboptimal vaccine uptake (deﬁned as the use
f a vaccine in an immunisation program). Vaccine hesitancy may
e due to a complex mix  of behavioral and social factors, and most
nterventions to increase vaccine acceptance have shown little or
o effect [5]. Furthermore, where hesitancy has been assumed to
e the root cause of poor vaccine uptake, closer study may  reveal
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264-410X/© 2015 The Authors. Published by Elsevier Ltd. This is an open access article 
/).the greater importance of other reasons related to, for example,
delivery of vaccination [6].
To effectively address a gap in coverage in a vaccination pro-
gram, we must therefore begin by identifying and weighting the
primary determinants of vaccine uptake. The root causes of subop-
timal uptake are complex and context-dependent, and even the
equation “vaccination uptake = access + acceptance” [7] seems too
simplistic to offer a viable explanation. A number of reviews have
identiﬁed, and several have recently attempted to classify, the myr-
iad possible determinants of vaccine hesitancy, and more broadly
vaccine uptake [8–15]. However, these classiﬁcations of possible
causal factors are often conceptual, focused on a single vaccine, or
difﬁcult to translate into practice.
There is a need for a pragmatic methodology to facilitate the
diagnosis of the possible root causes of a vaccination coverage gap
and support the subsequent design of a robust, evidence-based,
interventions. To this end, we aimed to develop a practical tax-
onomy for the myriad possible root causes of a vaccination gap.
Building upon a previous proposal of access plus acceptance[16],
we hypothesised four vaccination-related dimensions which could
inﬂuence vaccination uptake: Access, Affordability, Awareness, and
Acceptance. A ﬁfth dimension, Activation, was uncovered during
the review of the literature. Table 1 provide a working deﬁnition
for each of these ﬁve dimensions.
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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Table  1
Working deﬁnitions and contributing factors of the 5As.
Root cause Deﬁnition
Access The ability of individuals to be reached by, or to reach,
recommended vaccines
Affordability The ability of individuals to afford vaccination, both in
terms of ﬁnancial and non-ﬁnancial costs (e.g., time)
Awareness The degree to which individuals have knowledge of the
need for, and availability of, recommended vaccines
and their objective beneﬁts and risks
Acceptance The degree to which individuals accept, question or
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Activation The degree to which individuals are nudged towards
vaccination uptake
In this narrative review, we used these dimensions to organise
he literature to assess whether this was a reliable, comprehensive
nd operational taxonomy for the non socio-demographic deter-
inants of vaccine uptake.
. Method
.1. Search strategies
A search was conducted via Social Sciences Citation Index
SSCI)—1970-present, using the string (vacci* OR immuni*) AND
ptake, with the time span between 1st January 2003 to 29th
anuary 2013.
.2. Inclusion and exclusion criteria
A total of 485 records were exported in full into Excel. Abstracts
ere ﬁrst reviewed to identify eligible abstracts against the inclu-
ion and exclusion criteria (see Fig. 1). Literature was included if
he targeted vaccinations sourced from World Health Organisation
WHO) prequaliﬁed vaccinations [17] were mentioned in either the
bstract or title, this included the vaccination full name and the
ppropriate abbreviations (measles, mumps, rubella, MMR).
Human Papillomavirus (HPV) vaccine was excluded due to a
ecent review of factors associated with its uptake [18]. Equally,
nly the targeted countries were included: Estonia, Latvia, Lithua-
ia, Brazil, Venezuela, Columbia, Peru, Bolivia, Argentina, Chile,
igeria, Russia, India, Australia, United States (USA) and UK
England, Scotland and Wales).
Exclusion of literature included: Reviews, Editorial Material,
rticle proceedings paper and articles that did not mention the
argeted vaccinations or countries. Furthermore, articles were
lso excluded if in relation to other drugs, livestock/animal,
ood services, cost effectiveness, cost utility, feasibility, prenatal
(n = 33 ) Revi ews , E
(n = 3) Not  reporte
(n = 15 7) Targeted  V
(n = 10 4) Targeted  c
(n = 75) Not relevan
(n = 48 ) Insufficie nt 
(n = 12) Not relevan
(n = 6) Data not  re
(n = 4) Data relate
(n = 1) Data relate
(n = 4) Data ana ly 
420  ab strac ts excluded
27 abstracted excluded
485 abstracts reviewed
65 full  text articl es revi ewed
38 articl es revi ewed
Fig. 1. Flow chart of selection process f4 (2016) 1018–1024 1019
services/health services not inclusive of speciﬁc vaccination infor-
mation, disease control systems, infection rates, effect on cancer
rates, effects on uptake of cancer/hearing screening. Finally, arti-
cles were excluded when there was insufﬁcient or no information
provided in the title or abstract indicative of evidence pertaining to
the identiﬁcation of a barrier to, or driver for, vaccine uptake.
2.3. Data extraction and ﬁnal selection
The initial selection identiﬁed 65 articles. Full text papers were
obtained for each of these articles. A follow-up assessment of the
articles identiﬁed a further 27 articles that did not meet the exclu-
sion inclusion criteria, analysed data which preceded 2003, only
referred to socio-demographic determinants of vaccine uptake or
did not provide evidential statements in relation to barriers or
drivers of vaccine uptake where evidence included direct facts or
information to support the validity of the barrier or driver identiﬁed
(see Fig. 1).
2.4. Content analysis method
KR ﬁrst reviewed each selected article and recorded statements
providing evidence of a determinant of vaccine uptake in database
(e.g., “A signiﬁcantly higher proportion of infants born in hospi-
tals were vaccinated in the ﬁrst six weeks compared to those born
outside hospitals” [19]). She then categorised each piece of evi-
dence as pertaining to access, affordability, awareness, acceptance,
or other, using the deﬁnitions of each dimension (see Table 1). This
initial categorisation was reviewed and discussed with GVT and
disagreements were discussed and resolved through consensus.
Subsequently, KR coded the subcategories of evidence classiﬁed
under each dimension of the 4As. For example, the piece of evi-
dence mentioned above was  classiﬁed as evidence pertaining to
the location of uptake within the access dimension. Subcategories
were again reviewed and discussed with GVT and disagreements
were resolved through consensus. Finally, the ‘other’ dimension
was further content analysed and the factors identiﬁed were clas-
siﬁed into those that could be modiﬁed through an intervention
(subsequently labelled “activation factors”) and those that could
not (e.g., sociodemographic predictors of uptake, subsequently
excluded from the analysis).
3. Results3.1. Study characteristics
Of the 38 studies included in the ﬁnal sample, 15 studies
focused on Inﬂuenza (39%), 12 on MMR  (32%), 2 on DTP/DTP3, 1 on
ditorial Material , Article pr ocee ding s paper 
d in Englis h
accina tio n not mention ed
oun try no t men tion ed
t 
 or no in formation on  vacci ne up take
t or not providing appropriate information on vaccine uptake 
la ted to ba rriers or  drivers for vacci ne uptake
d to socio-demographic determinants of uptake
d to coun tries out side targe t
sed before 20 03
or inclusion of articles in review.
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Table 2
Vaccine, country of origin, method, sample sizes (N), and population tested for the studies reviewed.
Authors Vaccine Country Method N Respondents
Olusanya [19] BCG Nigeria Retrospective data 5171 Infants 0–3 mths
Athavale et al. [21] BCG UK Cohort data 557 Infants 0–3 mths
Elliott and Farmer [32] childhood immunisations India Survey 470 Parents (child aged 9 mths–6 yrs)
Antai  [10] childhood immunisations Nigeria Interviews 3725 Women  aged 15–49
Crocker et al. [11] DTP UK Survey 7 Health boards
Babalola et al. [20] DTP3 Nigeria Interviews 1,472 Men and women of reproductive age who have
children aged 12–35 months (one child per
household selected)
Marshall et al. [42] H1N1 Australia Survey 3936 General population
Brown, Kroll et al.[38] H1N1 UK Questionnaire 142 Parents
Ambrose and Sifakis [9] H1N1 USA Retrospective data 3320 38 schools in the 6 localities (students
enrolled)
Galarce et al. [12] H1N1 USA Survey 1569 Nationally representative sample of U.S. adults
age 18 and teachers (n = 58), others:
administrative staff, counsellors and media
specialistsGargano et al. [7] H1N1 USA Survey 66
Kumar et al. [40] H1N1 USA Survey 2079 Adults age 18+
Macdonald et al. [50] HBV Australia Observational 2085 Adults with no evidence of HBV immunity
Cox  et al. [26] HBV USA Interviews 1175 Adults recruited from three sexually
transmitted disease clinics in the USA  over 28
months.
Baars  et al. [44] Hep B USA Interviews 320 Men who have sex with men  (MSM)
Halliday et al. [22] Inﬂuenza Australia Survey 606 Staff in residential aged care facilities
Horby et al. [25] Inﬂuenza Australia Survey 7,681 Australians aged 65+
Dip  and Cabrera [39] Inﬂuenza Brazil Interviews 396 Elderly (age 60–95yrs)
Blank  et al. [29] Inﬂuenza European Questionnaire 15 15 countries: information regarding elderly
65+
Telford and Rogers [43] Inﬂuenza UK Interviews 20 Aged 75+
Holm  et al. [37] Inﬂuenza UK Survey 10,095 Population age 16+
Smedley et al. [27] Inﬂuenza UK Survey 6302 Healthcare workers
Uwemedimo et al. [48] Inﬂuenza USA Interviews 168 Non-Hispanic Black and Hispanic children
aged 6 months–3 years at the time of interview
Zhang et al. [35] Inﬂuenza USA Survey 522 Nurses
Chi  et al. [24] Inﬂuenza and Pneumococcal USA Survey 54,330 Aged 65+ Veterans
Lawrence et al. [33] MMR  Australia Interviews 506 Parents of children in sample
Brown,  Long et al. [47] MMR  UK Interviews 24 Mothers
Hilton et al. [46] MMR  UK Interviews 72 Parents
Jackson et al. [49] MMR  UK Interviews 142 Parents
Tickner et al. [36] MMR  UK Interviews 21 Parents (of child 2-5yrs)
Brown, Fraser et al. [8] MMR  UK Questionnaire 535 Parents of children aged 5–18
Brown, Shanley et al. [41] MMR  UK Questionnaire 365 Parents (child aged 5-18)
Cassell et al. [34] MMR  UK Questionnaire 452 Mothers (of child aged children aged
15–24mths)
Wroe et al. [45] MMR  UK Questionnaire 114 Parents
Bolton-Maggs et al. [23] MMR  UK Survey 2456 Students
Hamilton-West [31] MMR  UK Survey 252 Students
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epatitis B, 2 on BCG, 1 on Pneumococcal conjugate, 2 on childhood
mmunisations and 2 on HBV, (Table 2). Almost half of the studies
ere conducted within the United Kingdom (17/38). Sample size
anged from 7 to 66,362 (median 514): 31/38 (82%) studies had a
ample size greater than 100 and 15/38 (39%) exceeded a sample
ize of 1000. The majority of the included studies were either sur-
eys or questionnaires (22/38, 58%) or interviews (12/38, 32%), the
est consisted of retrospective, cohort, and observational data. The
argest group of respondents were parent(s) 12/38 (32%).
.2. Application of the 4As taxonomy
Evidence for a total of 23 factors inﬂuencing vaccine uptake
ere identiﬁed from the 38 articles reviewed, the largest category
eing Acceptance factors (12/23, 52%). Table 3 summarises the fac-
ors identiﬁed under each dimension of the initial 4As taxonomy
Access, Affordability, Awareness, Acceptance) as well as the factors
dentiﬁed under the ﬁfth dimension identiﬁed during the litera-
ure review (Activation). The following subsections summarise the
vidence for each factor identiﬁed.estionnaire 255 Parents (child aged 3–5yrs)
rvey 66,362 Child (19–35mths)
3.2.1. Access factors associated with vaccine uptake (n = 13)
Studies classiﬁed under this category revealed that access could
be mediated by the place of birth. Three studies conducted in
Nigeria found that a signiﬁcantly higher proportion of infants born
within a hospital, or a health facility had the highest proportion
of age appropriate immunisations [10,19,20]. The geographical
location of the vaccination also had an impact on uptake. Target-
ing parents prior to discharge from maternity units may  improve
BCG uptake [21]. Vaccine uptake was  also found to increase when
arranged by the workplace [22], University [23] or schools [9,11].
The role of access on vaccine uptake was also reﬂected in the impact
of regular contact with the health care system. Students who  were
registered with a GP were signiﬁcantly more likely to be vaccinated
with MMR  [23]. Elderly people in frequent contact with health care
services had higher vaccination rates than infrequent users [24],
and presence of a chronic disease may be an independent predic-
tor of inﬂuenza vaccination [25]. Finally, convenience of access was
also related to vaccine uptake. Uptake of HBV vaccine was  strongly
inﬂuenced by perceived inconvenience [26]. Vaccination programs
conducted within school hours had higher uptake than if the
A. Thomson et al. / Vaccine 3
Table  3
Summary of the contributing factors identiﬁed under each of the 5As dimensions.
Root cause Bibliographic source
1. Access
1.1. Place of birth 10, 19, 20
1.2. Location of vaccination 9, 11, 21, 22, 23
1.3. Contact with healthcare systems 23, 24, 25
1.4. Convenience of access 8, 26, 27
2.  Affordability
2.1. Financial incentives 28, 29
2.2. Time costs 27, 30, 31
3.  Awareness
3.1. Knowledge of vaccines and
vaccination schedule
32, 33, 34, 35
3.2. Availability of information 27, 36
3.3. Consideration of vaccination 37
4. Acceptance
4.1. Vaccine
4.1.1. Perceived safety 7, 12, 22, 27, 31, 35, 36, 38, 39, 40
4.1.2. Perceived efﬁcacy 22, 25, 27, 39
4.1.2. Attitude valence 8, 27, 31, 36, 40, 41
4.2. Disease
4.2.1. Perceived severity 7, 23, 37, 42
4.1.2. Vulnerability to risk 26, 35, 43, 44
4.3. Individual characteristics
4.3.1. Health beliefs 34
4.1.2. Omission bias 31, 38, 45
4.1.3. Trust 43, 46, 47
4.1.3. Past behaviour 12, 22, 36, 40, 48
4.4. Social context
4.2.1. Social responsibility 8, 36, 47
4.1.2. Peer inﬂuence 20, 31
4.1.3. HCW inﬂuence 7, 36, 37, 44
5.  Activation
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C5.1. Prompts and reminders 20, 22, 29, 32, 48, 49, 50
5.2. Workplace policies 22, 29
rogram was after school hours [8]. Over one-third of UK health-
are workers stated they could be persuaded to vaccinate in future
f access was more convenient [27].
.2.2. Affordability factors associated with vaccine uptake (n = 5)
Only two studies among the selected sample examined the
mpact of ﬁnancial incentives on vaccine uptake. A US study found
n association between state ﬁnancing policy and full course
neumococcal vaccination [28]. The delivery of vouchers for free
nﬂuenza vaccination was a contributing factor to high vaccine
ptake in the elderly [29]. Three additional studies examined the
mpact of non-ﬁnancial costs on vaccine uptake, with time costs as
he most prominent non-ﬁnancial affordability constraints. Parents
f children aged 2–5 years reported commitments such as work
r other children as a barrier to timely immunisation [30]. Lack
f time to attend a vaccination clinic was a stated deterrent for
accine uptake in 22% of HCWs surveyed [27], and was a
able 4
omparison of the dimensions highlighted by existing taxonomies for the root causes of a
Tailoring immunisation
programs (TIP) (key issues)
UNVACC (core problem areas) 
Environmental opportunity
factors
Physical access to health
services
Supportive ability factors Missed opportunities during
health service delivery
Personal  motivation factors Health worker knowledge,
practice & attitude
Vaccine availability 
Care-giver information, beliefs
& attitudes
Community/societal factors4 (2016) 1018–1024 1021
signiﬁcant predictor of non-vaccination with MMR  in university
students [31].
3.2.3. Awareness factors associated with vaccine uptake (n = 10)
The most common reasons given by parents for failure to vac-
cinate were poor education and lack of knowledge about the
vaccination schedule [32,33]. Conversely, non-compliers of vacci-
nation were signiﬁcantly more likely to have attended meetings
and to have read books on MMR  [34]. Increased knowledge of vac-
cines also improves uptake among HCWs: UK  nurses with high
knowledge levels were more likely to get vaccinated than those
with low knowledge [35]. Besides acquired knowledge, the amount
of information available was  associated with lower uptake inten-
tions. Parents were dissatisﬁed with the lack of information about
pre-school doses and the lack of contact with a HCW,  leading
some to question the importance of pre-school immunisation [36].
Conversely, those provided with more information about personal
beneﬁt and risk were more willing to be vaccinated [27]. One  of
the most frequent reasons for not receiving inﬂuenza vaccination
among UK respondents was  simply not having considered immun-
isation [37].
3.2.4. Acceptance factors associated with vaccine uptake
Acceptance was  the most commonly researched aspect of vac-
cine uptake. The acceptance factors identiﬁed pertained to the
vaccine itself, the disease it aims to protect individuals from, indi-
vidual characteristics, as well as the social context.
3.2.4.1. Acceptance factors related to the vaccine (n = 13). Safety
concerns including side effects associated with vaccination
can have disproportionately detrimental effects on uptake
[7,12,22,27,31,35,36,38–40]. For instance, if a vaccine is believed
to be safe, vaccination is ﬁve times more likely than if it is deemed
unsafe [12]. Other determinant factors included concerns or lack
of belief in vaccine efﬁcacy [22,25,27,39]. Finally general attitudes
towards the vaccine were also predictors of vaccine uptake. Par-
ents with maximum intention to have their child vaccinated had
more positive beliefs in regards to MMR  vaccine [36]. Likewise pos-
itive MMR  attitudes independently predicted uptake for both MMR
doses [8,41] as were perceived beneﬁts of vaccines and vaccination
[27,31,40].
3.2.4.2. Acceptance factors related to the disease (n = 8). A higher
perceived severity of a disease increases the intention to receive
vaccination [7,23,37,42]. Conversely, perception of inﬂuenza as a
mild disease reduced willingness to get vaccinated [42]. Other
factors associated with vaccine acceptance included the level of
perceived risk and vulnerability to the infection was  [26,35,43,44].3.2.4.3. Acceptance factors related to individual characteristics
(n = 12). Individual health beliefs were found to inﬂuence vacci-
nation acceptance. Mothers who had consulted a homeopath, or
 vaccination gap.
SAGE working group (determinants of
vaccine hesitancy)
5As (root causes)
Contextual inﬂuences Access
Vaccine and vaccination-speciﬁc issue Affordability
Individual/social group inﬂuences Awareness
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ho believed that “it is better to get immunity naturally” were sig-
iﬁcantly less likely to immunise their children with MMR  [34].
imilarly, individuals’ emotions and cognitive biases have been
hown to inﬂuence uptake. Omission bias, in which harm from
n action is rated less favourably than harm from inaction even
hen those outcomes are objectively similar, was  also identiﬁed
s a barrier to vaccination decisions [31,38,45]. Individuals’ feel-
ngs of trust were also related to acceptance. Signiﬁcantly more
others who expressed lack of trust in the government or in phar-
aceutical companies did not vaccinate their children with MMR
46]. Trust in health professionals and vaccine policy was  found
o be central to acceptance of MMR  [47] as is trust of modern
edicine for inﬂuenza uptake in the elderly [43]. Besides cognitive
nd emotional individual characteristics, past behaviour and pre-
ious vaccination acceptance was also a strong predictor of vaccine
ptake [12,22,36,40,48].
.2.4.4. Acceptance factors related to the social context (n = 8). Social
ttitudes, including viewing vaccination as a social responsibility
nd the feeling that one ought to protect others’ children pre-
icted uptake [8,36,47]. Peer inﬂuence is also important. In Nigeria,
erceived social approval signiﬁcantly predicted DTP3 uptake [20]
hile perceived peer acceptance of MMR  vaccination signiﬁcantly
redicted uptake in university students [31]. Finally, personal
ecommendations by HCWs were also found to have a strong nor-
ative inﬂuence on vaccine uptake among patients, parents, or
eachers [7,36,37,44].
.2.5. Activation factors associated with vaccine uptake (n = 8)
A few studies mentioned factors associated with vaccine uptake
hich were not anticipated by the 4As taxonomy, calling for a ﬁfth
imension, which we labelled Activation. Activation refers to the
ctions that nudge people who intend to get vaccinated towards
accine uptake. Two types of nudging techniques to boost activa-
ion were identiﬁed: Prompts and reminders as well as workplace
olicies. Children attending facilities with reminder systems in
lace were ﬁve times more likely to receive a ﬂu vaccine, in compar-
son to healthcare facilities without these systems [48]. Similarly,
roviding reminders to staff in aged care facilities signiﬁcantly
ncreased inﬂuenza vaccination uptake [22] and children in Nigeria
ith immunisations cards were 2.5 times more likely to be immu-
ised than those without the cards [20,32]. Likewise, providing
 leaﬂet and a parent meeting [49], sending of a personal letter
29], decreasing the time lag between consultation and vaccina-
ion [50] were all associated with higher vaccine uptake. Finally,
orkplace policies and practices such as information to HCW staff
22] and predetermined targets for HCW vaccination coverage was
lso associated with vaccination uptake [29].
. Discussion
The objective of this narrative review was to determine whether
he 4 domains of Access,  Affordability, Awareness and Acceptance
ould adequately describe and organise all of the non-socio-
emographic determinants of vaccine uptake. We  deliberately
ought to develop a taxonomy that may  facilitate the identiﬁca-
ion and analysis by public health practitioners and vaccination
rogram managers of the multiple causes that may  underpin
 vaccination coverage gap, to inform the implementation of
vidence-based interventions. Compared to other classiﬁcations
f determinants of uptake, this taxonomy is deliberatively sim-
le, intuitive and alliterative, with the express aim of facilitating mutual understanding of a complex problem (see Table 4 for a
omparison of existing classiﬁcation schemes). Socio-demographic
actors were excluded from this taxonomy because these fac-
ors, while important, cannot be inﬂuenced by interventions. This4 (2016) 1018–1024
review identiﬁed a ﬁfth domain, Activation,  which interestingly
captured some of the most effective interventions.
Consistent with many studies that have shown that provision
of information and increased knowledge (Awareness) may  not
change intentions or behaviours [16,51], these ﬁndings suggest that
although there is a relationship between knowledge and accep-
tance, it is far from straightforward. Awareness and knowledge
may  be associated with an increase in acceptance among practition-
ers, but with a decrease in uptake in the general public. Moreover,
in many contexts, access to, and affordability (both ﬁnancial and
non-ﬁnancial costs) of immunisation remain barriers to uptake.
Another ﬁnding was  that the most commonly studied predic-
tors of vaccination uptake were related to Acceptance.  Consistent
with a traditional psychological approach to the study of the deter-
minants of health behaviour (e.g., the health belief model [52] or
the theory of planned behaviour [53,54]), factors included judge-
ments about one’s susceptibility to contract an infectious disease,
the perceived severity of a contamination as well as perceived ben-
eﬁts and judged efﬁcacy of vaccination, concerns about side effects
and the impact of social norms. Interestingly, using Acceptance as a
coding category also highlighted additional possible determinants
such as trust, cognitive biases and past behaviours.
The ﬁfth classiﬁcation that we termed Activation (deliberately
alliterative) emerged from this study in the form of interventions
that made vaccination as easy as possible through facilitation of
access, made it a net positive, rather than negative, experience with
small incentives [49], made vaccination the default rather than a
choice, or provided reminders [40].
There is some ambiguity and possible overlap between the
A’s for some factors. Convenience could, for example, be Access,
Affordability, or Activation depending on the context and interpre-
tation. However, the 5As taxonomy has been developed here with
a very pragmatic objective—to facilitate the classiﬁcation and char-
acterisation of various possible determinants of a coverage gap by
an inter-sectorial working group. Thus, this taxonomy should be
conceived as a set of working deﬁnitions rather than a rigid nomen-
clature.
4.1. Limitations of the review
Although this systematic review attempted to cast a wide net
over many countries and vaccinations, developing countries were
underrepresented and many vaccines were not included in the
analysis. The vast majority of research was  conducted within the
UK, USA and Australia (86%). We should thus be cautious in assum-
ing that these results can be generalised or have a strong degree
of applicability to understand the vaccination gap in developing
countries or for a variety of vaccines.
Moreover, we did not conduct a meta-analysis of the weight
of the determinants identiﬁed given the variance in vaccine type,
populations and countries. As such, this study did not aim to
comprehensively capture nor weight the various determinants of
vaccine uptake. Instead, it was intended to provide a preliminary
proof-of-concept for using the 5As as a conceptual framework to
identify and classify the different determinants of vaccine uptake
with a view to inform future research and interventions aiming to
reduce immunisation gaps.
5. Conclusions
Previous research on vaccine uptake has identiﬁed a multi-
tude of potential determinants. As a result, it is difﬁcult to decide
which determinant should be targeted when designing interven-
tions to improve uptake. The 5As taxonomy effectively captured all
of the determinants of vaccine uptake identiﬁed in this literature
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eview. Future research may  use this taxonomy to systemati-
ally compare and weight the importance of each of the 5As in
xplaining a vaccination gap for different vaccines or for one vac-
ine in different socio-cultural contexts. This in turn, would allow
argeted, research-informed, interventions aiming to increase cov-
rage rates. This taxonomy is currently being tested in pilots of
n integrated approach to diagnose and improve a vaccination
ap. It has already effectively facilitated a mutual understanding
f the primary determinants of suboptimal coverage among inter-
ectorial working groups in four countries, a ﬁrst step towards them
eveloping targeted and effective solutions.
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